Next generation sequencing reveals a novel pathogenic variant in the ATMgene
Introduction: Ataxia telangiectasia (A-T) is a uncommon autosomal recessive multisystemic illness. Sufferers with the A-T syndrome current a broad spectrum of illness phenotypes. The ATM (ataxia telangiectasia mutated) gene, the one causative gene for A-T.
Methodology: A affected person of Persian origin presenting with typical A-T was referred to our genetics middle for specialised genetic counseling and testing. Focused next-generation sequencing (NGS) was utilized. Sanger sequencing was used to substantiate the candidate variant. Modeling was carried out utilizing the SWISS-MODEL server.Outcomes: A homozygous stop-gain variant c.829G > T (p.E277*) was discovered within the ATM gene. This variant was confirmed by Sanger sequencing and modeling of native construction and truncated construction was carried out.
Conclusion: Thus far, only a few pathogenic variants of the ATM gene have been reported from the Iranian inhabitants. The discovering has implications in molecular diagnostic for A-T in Iran.
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-100mL | Elabscience Biotech | 100mL | EUR 80 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-20mL | Elabscience Biotech | 20mL | EUR 25 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-50mL | Elabscience Biotech | 50mL | EUR 60 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-each | Elabscience Biotech | each | Ask for price |
Strong RIPA Lysis Buffer |
|||
EZPS03-1 | Shanghai WSHT Biotechnology | 100mL | EUR 15 |
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-100mL | MyBiosource | 100mL | EUR 210 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-5x100mL | MyBiosource | 5x100mL | EUR 640 |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
Clear Seal Strong Sheet (100) |
|||
MAAB-0685 | Westburg | each | EUR 255.61 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
Tissue/cell lysis buffer(Strong) |
|||
RM17482 | Abclonal | 10mL | EUR 53.14 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
anti PAI-1 (very strong for human) |
|||
MBS480230-1mg | MyBiosource | 1mg | EUR 790 |
anti PAI-1 (very strong for human) |
|||
MBS480230-5x1mg | MyBiosource | 5x1mg | EUR 3315 |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 48 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 431 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 113 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
Seralite SRC-120, Strong Acid Cation Exchange Resin |
|||
14891 | Sisco Laboratories | 500 Gms | EUR 3.76 |
Description: Part A |
Seralite SRA-400, Strong Basic Anion Exchange Resin |
|||
52228 | Sisco Laboratories | 500 Gms | EUR 5.82 |
Description: Part A |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 192 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 62 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 1150 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 69011-15-0 |
Genistin |
|||
540154 | MedKoo Biosciences | 500.0mg | EUR 450 |
Genistin |
|||
1535-10 | Biovision | each | EUR 196.8 |
Genistin |
|||
GC2802 | Glentham Life Sciences | 10mg | EUR 1689.94 |
Genistin |
|||
G350020 | Toronto Research Chemicals | 10mg | EUR 63 |
Description: 529-59-9 |
Genistin |
|||
HY-N0595 | MedChemExpress | 50mg | EUR 170.4 |
Genistin |
|||
N1860-20 | ApexBio | 20 mg | EUR 100 |
Description: TdT inhibitor |
Genistin |
|||
GC2802-10 | Glentham Life Sciences | 10 | EUR 242.4 |
Genistin |
|||
GC2802-100 | Glentham Life Sciences | 100 | EUR 960.1 |
Genistin |
|||
GC2802-25 | Glentham Life Sciences | 25 | EUR 382.3 |
Genistin |
|||
GC2802-250 | Glentham Life Sciences | 250 | EUR 1845.7 |
Genistin |
|||
GC2802-50 | Glentham Life Sciences | 50 | EUR 577.8 |
Genistin |
|||
T2882-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Genistin |
Genistin |
|||
abx282781-100g | Abbexa | 100 µg | Ask for price |
Genistin |
|||
abx282781-20g | Abbexa | 20 µg | EUR 106.25 |
Genistin |
|||
abx282781-50g | Abbexa | 50 µg | EUR 250 |
Genistin |
|||
TB0370-1000 | ChemNorm | 4X20mg | EUR 321.6 |
Genistin |
|||
MBS6086497-100mg | MyBiosource | 100mg | EUR 380 |
Genistin |
|||
MBS6086497-25mg | MyBiosource | 25(mg | EUR 295 |
Genistin |
|||
MBS6086497-50mg | MyBiosource | 50mg | EUR 320 |
Genistin |
|||
MBS6086497-5x100mg | MyBiosource | 5x100(mg | EUR 1560 |
Genistin |
|||
MBS3608735-100mg | MyBiosource | 100mg | EUR 250 |
Genistin |
|||
MBS3608735-200mg | MyBiosource | 200mg | EUR 275 |
Genistin |
|||
MBS3608735-25mg | MyBiosource | 25mg | EUR 210 |
Genistin |
|||
MBS3608735-50mg | MyBiosource | 50mg | EUR 220 |
Genistin |
|||
MBS3608735-5x200mg | MyBiosource | 5x200mg | EUR 930 |
Genistin |
|||
MBS576468-100mg | MyBiosource | 100mg | EUR 180 |
Genistin |
|||
MBS576468-10mg | MyBiosource | 10mg | EUR 145 |
Genistin |
|||
MBS576468-200mg | MyBiosource | 200mg | EUR 210 |
Genistin |
|||
MBS576468-50mg | MyBiosource | 50mg | EUR 155 |
Genistin |
|||
MBS576468-5mg | MyBiosource | 5mg | EUR 145 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 9052-45-3 |
Genistin, >99% |
|||
BC034-025 | GenDepot | 25mg | EUR 278.4 |
Genistin, >99% |
|||
BC034-050 | GenDepot | 50mg | EUR 327.6 |
Genistin, >99% |
|||
BC034-100 | GenDepot | 100mg | EUR 537.6 |
Genistin(Genistoside) |
|||
E1KS2301 | EnoGene | 25mg | EUR 211.2 |
Genistin (Genistoside) |
|||
MBS8506424-25mg | MyBiosource | 25mg | EUR 290 |
Genistin (Genistoside) |
|||
MBS8506424-5x25mg | MyBiosource | 5x25mg | EUR 1150 |
Genistin (Genistoside) |
|||
MBS384753-100mg | MyBiosource | 100mg | EUR 190 |
Genistin (Genistoside) |
|||
MBS384753-25mg | MyBiosource | 25mg | EUR 140 |
Genistin (Genistoside) |
|||
MBS384753-50mg | MyBiosource | 50mg | EUR 160 |
Genistin (Genistoside) |
|||
MBS384753-5x100mg | MyBiosource | 5x100mg | EUR 855 |
Genistin malonate |
|||
TB0588-0005 | ChemNorm | 10mg | EUR 886.8 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 850 |
Genistin 6''-O-Acetate |
|||
G350030 | Toronto Research Chemicals | 100mg | EUR 7600 |
Description: 73566-30-0 |
Genistin 6''-O-Malonate |
|||
G350035 | Toronto Research Chemicals | 250mg | EUR 11200 |
Description: 51011-05-3 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 850 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity |
|||
DAG-YS23-29 | Creative Diagnostics | 25 mL | EUR 850 |
Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk |
|||
MS1000-F2 | Benchmark Scientific | 1 each | EUR 149.35 |
Estrogen receptor (ER) IHC control with strong, moderate, low/negative expressersHumanBreastBreastIHC control |
|||
ERC083 | Pantomics | 1.5mm | EUR 50 |
genesig Easy kit for Strongylus vulgaris |
|||
Z-Path-S.vulgaris-EASY | Novacyt Group | 50 tests | EUR 410 |
Description: S.vulgaris |
Rat Strongyloid IgG |
|||
QY-E11978 | Qayee Biotechnology | 96T | EUR 420 |
Strongyloides IgG/IgM |
|||
DESTRO0690 | Demeditec Diagnostics | 96 | EUR 134 |
Strongyloides ELISA Kit |
|||
MBS495518-5x96Tests | MyBiosource | 5x96Tests | EUR 2380 |
Strongyloides ELISA Kit |
|||
MBS495518-96Tests | MyBiosource | 96Tests | EUR 520 |
Strongzyme Goat anti Mouse IgG (H+L) (HRP) |
|||
43R-1653 | Fitzgerald | 1 ml | EUR 763.2 |
Description: Strongzyme Goat anti-Mouse IgG (H+L) secondary antibody (HRP) |
Strongzyme Rabbit anti Goat IgG (H+L) (HRP) |
|||
43R-1650 | Fitzgerald | 1 ml | EUR 813 |
Description: Strongzyme Rabbit anti Goat IgG (H + L) (HRP) secondary antibody |
Strongzyme Goat anti Rabbit IgG (H + L) (HRP) |
|||
43R-1652 | Fitzgerald | 1 ml | EUR 648 |
Description: Strongzyme Goat anti Rabbit IgG (H + L) secondary antibody (HRP) |
QPCR Kit DNA Strongylus vulgaris |
|||
MOL8942 | Scientific Laboratory Supplies | EACH | EUR 987.17 |
Human Strongyloides IgG Elisa Kit |
|||
EK713927 | AFG Bioscience LLC | 96 Wells | EUR 0.4 |
QPCR Kit DNA Strongylus vulgaris - EACH |
|||
MOL8940 | Scientific Laboratory Supplies | EACH | EUR 1129.51 |
genesig Real-time PCR detection kit for Strongylus vulgaris |
|||
Z-Path-S-vulgaris | Novacyt Group | 150 tests | EUR 808 |
Description: S.vulgaris |
genesig Std Real-time PCR detection kit, Strongylus vulgaris |
|||
Z-Path-S-vulgaris-std | Novacyt Group | 150 tests | EUR 602 |
Description: S.vulgaris |
Strongyloides (IgG/IgM) ELISA Kit (Human) (OKNA00174) |
|||
OKNA00174 | Aviva Systems Biology | 96 Wells | EUR 505.2 |
Description: Description of target: Strongyloides is a genus containing some 50 species of obligate gastrointestinal parasites of vertebrates. Strongyloides stercoralis is the scientific name of a human parasitic roundworm causing the disease of strongyloidiasis. Its common name is pinworm in the UK and threadworm in the US. The Strongyloides stercoralis nematode can parasitize humans. The adult parasitic stage lives in tunnels in the mucosa of the small intestine.S. stercoralis can be found in areas with tropical and subtropical climates but cases also occur in temperate area, more frequently in rural areas. S. stercoralis has a very low prevalence in societies where fecal contamination of soil or water is rare. Many people infected are usually asymptomatic at first. Symptoms include dermatitis: swelling, itching, larva currens, and mild hemorrhage at the site where the skin has been penetrated. If the parasite reaches the lungs, the chest may feel as if it is burning, and wheezing and coughing may result, along with pneumonia-like symptoms (Löffler's syndrome). The intestines could eventually be invaded, leading to burning pain, tissue damage, sepsis, and ulcers. In severe cases, edema may result in obstruction of the intestinal tract, as well as loss of peristaltic contractions. Strongyloides infection in immunocompromised individuals (particularly following the administration of steroids, for example following transplant surgery) can result in disseminated strongyloidiasis, in which worms move beyond the confines of the gut into other organs. This is fatal unless antiStrongyloides therapy is given.Locating juvenile larvae, either rhabditiform or filariform, in recent stool samples will confirm the presence of this parasite. Other techniques used include direct fecal smears, culturing fecal samples on agar plates, serodiagnosis through ELISA, and duodenal fumigation.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: 87.9% |
StrongZyme Streptavidin-PolyHRP (High Load) |
|||
43R-1645 | Fitzgerald | 1 mg | EUR 380 |
Description: StrongZyme Streptavidin-PolyHRP conjugate (High Load) |
Rat Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392751-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Rat Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392751-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Rat Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392751-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Rat Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392751-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Mouse Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392747-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Mouse Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392747-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Mouse Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392747-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Mouse Strongyloides Stercoralis Antibody (SS-IgM) ELISA Kit |
|||
MBS9392747-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Recombinant Strongylocentrotus purpuratus Bindin |
|||
MBS1128565-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1120 |
Recombinant Strongylocentrotus purpuratus Bindin |
|||
MBS1128565-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 745 |
Recombinant Strongylocentrotus purpuratus Bindin |
|||
MBS1128565-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 910 |
Recombinant Strongylocentrotus purpuratus Bindin |
|||
MBS1128565-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 895 |
Recombinant Strongylocentrotus purpuratus Bindin |
|||
MBS1128565-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1065 |
Recombinant Strongylocentrotus purpuratus Univin |
|||
MBS1241085-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Strongylocentrotus purpuratus Univin |
|||
MBS1241085-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 625 |
Recombinant Strongylocentrotus purpuratus Univin |
|||
MBS1241085-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 800 |
Recombinant Strongylocentrotus purpuratus Univin |
|||
MBS1241085-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 725 |
Recombinant Strongylocentrotus purpuratus Univin |
|||
MBS1241085-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 935 |
Recombinant Strongylocentrotus purpuratus Histone H4 |
|||
MBS1043420-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1025 |
Recombinant Strongylocentrotus purpuratus Histone H4 |
|||
MBS1043420-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 600 |
Recombinant Strongylocentrotus purpuratus Histone H4 |
|||
MBS1043420-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 780 |
Recombinant Strongylocentrotus purpuratus Histone H4 |
|||
MBS1043420-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 695 |
Recombinant Strongylocentrotus purpuratus Histone H4 |
|||
MBS1043420-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 910 |
Recombinant Strongylocentrotus purpuratus Profilin |
|||
MBS1143303-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1065 |
Recombinant Strongylocentrotus purpuratus Profilin |
|||
MBS1143303-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 650 |
Recombinant Strongylocentrotus purpuratus Profilin |
|||
MBS1143303-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 815 |
Recombinant Strongylocentrotus purpuratus Profilin |
|||
MBS1143303-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 750 |
Recombinant Strongylocentrotus purpuratus Profilin |
|||
MBS1143303-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 955 |
Recombinant Strongylocentrotus franciscanus Bindin |
|||
MBS1245544-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1120 |
Recombinant Strongylocentrotus franciscanus Bindin |
|||
MBS1245544-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 745 |
Recombinant Strongylocentrotus franciscanus Bindin |
|||
MBS1245544-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 910 |
Recombinant Strongylocentrotus franciscanus Bindin |
|||
MBS1245544-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 895 |
Recombinant Strongylocentrotus franciscanus Bindin |
|||
MBS1245544-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1065 |
Recombinant Strongylocentrotus purpuratus Tektin-B1 |
|||
MBS1372801-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1270 |
Recombinant Strongylocentrotus purpuratus Tektin-B1 |
|||
MBS1372801-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 945 |
Recombinant Strongylocentrotus purpuratus Tektin-B1 |
|||
MBS1372801-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1065 |
Recombinant Strongylocentrotus purpuratus Tektin-B1 |
|||
MBS1372801-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1135 |
Recombinant Strongylocentrotus purpuratus Tektin-B1 |
|||
MBS1372801-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1210 |
Recombinant Strongylocentrotus purpuratus Late histone H2B.L1 |
|||
MBS1210922-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Strongylocentrotus purpuratus Late histone H2B.L1 |
|||
MBS1210922-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 625 |
Recombinant Strongylocentrotus purpuratus Late histone H2B.L1 |
|||
MBS1210922-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 800 |
Recombinant Strongylocentrotus purpuratus Late histone H2B.L1 |
|||
MBS1210922-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 725 |
Recombinant Strongylocentrotus purpuratus Late histone H2B.L1 |
|||
MBS1210922-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 935 |
Recombinant Strongylocentrotus purpuratus Late histone H2A.L3 |
|||
MBS1196903-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Strongylocentrotus purpuratus Late histone H2A.L3 |
|||
MBS1196903-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 625 |
Recombinant Strongylocentrotus purpuratus Late histone H2A.L3 |
|||
MBS1196903-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 800 |
Recombinant Strongylocentrotus purpuratus Late histone H2A.L3 |
|||
MBS1196903-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 730 |
Familial dilated cardiomyopathy brought on by a novel variant within the Lamin A/C gene: a case report
Background: Familial dilated cardiomyopathy (FDCM) is mostly inherited as an autosomal dominant trait. The Lamin A/C (LMNA) gene variants have been recognized to be related to DCM, conductive system problems, kind 2 Emery-Dreifuss muscular dystrophy and a number of other different problems. Right here, we reported a novel variant within the LMNA gene that is likely to be associated to FDCM.
Case presentation: A 30-year-old younger man was hospitalized for chest tightness, excessive fatigue, palpitation and impaired exercise tolerance. He had scientific traits together with cardiac dilatation, atrial tachyarrhythmia, extreme conductive system problems, and dyskinesia of each higher limbs and the neck. Genetic sequence evaluation indicated that the affected person carried a novel c.1325 T>C heterozygous LMNA gene variant. Catheter ablation and cardiac resynchronization remedy with pacing perform (CRT-P) have been carried out to deal with the arrhythmia.
Conclusion: The variant c.1325 T>C is a novel variant within the LMNA gene that has not been beforehand reported. Younger sufferers with DCM, conductive system problems and skeletal myopathy ought to be alert to the potential for LMNA gene variant. Cardiac resynchronization remedy (CRT) could also be an affordable selection for affected person carrying a LMNA gene variant with third-degree atrioventricular block even when the left ventricular ejection fraction is preserved with the intention to stop the deterioration of cardiac perform brought on by proper ventricular pacing dependency.
Genetic evaluation of kids with congenital ocular anomalies in three ecological areas of Nepal: a section II of Nepal pediatric ocular illnesses research
Background: Genetic eye illnesses represent a big and heterogeneous group of childhood ocular morbidity. Particular person illnesses could trigger a number of structural anomalies and developmental options. Nepal Pediatric Ocular Illness Research (NPODS) was a population-based epidemiological research carried out throughout three ecological areas of Nepal to find out the prevalence and etiology of childhood ocular morbidity and blindness. In Part II of this research, genetic evaluation was carried out for kids who have been discovered to have congenital ocular anomalies.
Methodology: It was a cross sectional descriptive research. A complete of 10,270 youngsters throughout three totally different ecological areas in Nepal (Low lands, hills, and mountains) underwent ocular examinations in NPODS. Out of 374 (3.6%) of kids with ocular abnormalities, 30 have been considered congenital in nature. Focused genetic evaluation, together with genotyping for genes particular to presenting phenotype, was carried out for 25 youngsters utilizing serum samples.
Outcomes: Out of 25 youngsters, 18 had significant genetic outcomes. Evaluation revealed one missense alteration G12411T of Zinc Finger Homeobox 4 (ZFHX4) gene in a single participant amongst 10 with congenital ptosis and one other missense variation T > C P. Y374 C of Signaling Receptor and Transporter Retinol 6 (STRA6) gene in a single participant amongst Three with microphthalmos.
Conclusion: The research is first of its sort from Nepal and mutant genes have been distinctive to Nepalese Inhabitants. Additional evaluation of genetic components is essential to higher perceive genetic affiliation with ocular illnesses and situations. This helps additional in genetic counseling and doubtless gene remedy to forestall blindness from these situations.
Doxorubicin hydrochloride |
|||
100280 | MedKoo Biosciences | 100.0mg | EUR 150 |
Doxorubicin Hydrochloride |
|||
40410004-1 | Glycomatrix | 10 mg | EUR 136.34 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Glycomatrix | 25 mg | EUR 273.17 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 176.4 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin Hydrochloride |
|||
SIH-390-10MG | Stressmarq | 10 mg | EUR 129 |
Description: Apoptosis Inducer |
Doxorubicin Hydrochloride |
|||
SIH-390-50MG | Stressmarq | 50 mg | EUR 465 |
Description: Apoptosis Inducer |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin Hydrochloride |
|||
MBS651404-25mg | MyBiosource | 25mg | EUR 460 |
Doxorubicin Hydrochloride |
|||
MBS651404-5x25mg | MyBiosource | 5x25mg | EUR 1925 |
Doxorubicin Hydrochloride |
|||
MBS808094-10mg | MyBiosource | 10mg | EUR 250 |
Doxorubicin Hydrochloride |
|||
MBS808094-50mg | MyBiosource | 50mg | EUR 570 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x10mg | MyBiosource | 5x10mg | EUR 880 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x50mg | MyBiosource | 5x50mg | EUR 2300 |
Doxorubicin hydrochloride |
|||
MBS3603751-100mg | MyBiosource | 100mg | EUR 210 |
Doxorubicin hydrochloride |
|||
MBS3603751-200mg | MyBiosource | 200mg | EUR 245 |
Doxorubicin hydrochloride |
|||
MBS3603751-25mg | MyBiosource | 25mg | EUR 195 |
Doxorubicin hydrochloride |
|||
MBS3603751-500mg | MyBiosource | 500mg | EUR 315 |
Doxorubicin hydrochloride |
|||
MBS3603751-5x500mg | MyBiosource | 5x500mg | EUR 1075 |
Doxorubicin hydrochloride, 98% |
|||
GP9056 | Glentham Life Sciences | 25mg | EUR 128.36 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-25 | Glentham Life Sciences | 25 | EUR 56.1 |
Doxorubicin hydrochloride USP |
|||
D005-10MG | TOKU-E | 10 mg | EUR 117.34 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride USP |
|||
D005-25MG | TOKU-E | 25 mg | EUR 234.67 |
Description: C27H29NO11•HCl |
10 mM Doxorubicin hydrochloride |
|||
DOX10 | ProFoldin | 100 ul | EUR 92 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969 | Glentham Life Sciences | 10mg | EUR 137.69 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-10 | Glentham Life Sciences | 10 | EUR 47.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-100 | Glentham Life Sciences | 100 | EUR 150.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-25 | Glentham Life Sciences | 25 | EUR 67.2 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-50 | Glentham Life Sciences | 50 | EUR 95 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-100mg | MyBiosource | 100(mg | EUR 435 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-1g | MyBiosource | 1g | EUR 1045 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-250mg | MyBiosource | 250mg | EUR 615 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-500mg | MyBiosource | 500mg | EUR 825 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-5x1g | MyBiosource | 5x1g | EUR 4560 |
Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%) |
|||
D399610 | Toronto Research Chemicals | 250mg | EUR 150 |
Doxorubicinol hydrochloride |
|||
T40736-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
MBS5800915-5mg | MyBiosource | 5(mg | EUR 915 |
Doxorubicinol hydrochloride |
|||
MBS5800915-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Doxorubicinol Hydrochloride (>90%) (Mixture of diastereomers) |
|||
D558020 | Toronto Research Chemicals | 10mg | EUR 141 |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin |
|||
abx188695-1g | Abbexa | 1 g | EUR 560.4 |
Doxorubicin |
|||
D063-100MG | TOKU-E | 100 mg | EUR 1261.2 |
Doxorubicin |
|||
D063-25MG | TOKU-E | 25 mg | EUR 131.79 |
Description: C27H29NO11 |
Doxorubicin |
|||
D063-5MG | TOKU-E | 5 mg | EUR 460.82 |
Description: C27H29NO11 |
Doxorubicin |
|||
A3966-10 | ApexBio | 10 mg | EUR 48 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-100 | ApexBio | 100 mg | EUR 154 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-25 | ApexBio | 25 mg | EUR 67 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Doxorubicin |
|||
MBS3840348-100mg | MyBiosource | 100mg | EUR 165 |
Doxorubicin |
|||
MBS3840348-500mg | MyBiosource | 500mg | EUR 345 |
Doxorubicin |
|||
MBS3840348-50mg | MyBiosource | 50mg | EUR 135 |
Doxorubicin |
|||
MBS3840348-5x500mg | MyBiosource | 5x500mg | EUR 1550 |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin [BSA] |
|||
DAG-WT1084B | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin [OVA] |
|||
DAG-WT1084O | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-HCl |
|||
MBS406798-1mg | MyBiosource | 1mg | EUR 1205 |
Doxorubicin-HCl |
|||
MBS406798-5x1mg | MyBiosource | 5x1mg | EUR 5385 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-MVCP |
|||
MBS5781169-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Doxorubicin-SMCC |
|||
HY-116063 | MedChemExpress | 10 mg | EUR 919.93 |
Description: Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin[1]. |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-10mg | MyBiosource | 10mg | EUR 680 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-1mg | MyBiosource | 1(mg | EUR 320 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-25mg | MyBiosource | 25mg | EUR 1495 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5mg | MyBiosource | 5mg | EUR 435 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5x25mg | MyBiosource | 5x25mg | EUR 6570 |
Doxorubicin-13C,d3 (TFA) |
|||
HY-15142AS1 | MedChemExpress | 1mg | Ask for price |
Description: Doxorubicin-13C,d3 (TFA) is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stoppin |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-10mg | MyBiosource | 10mg | EUR 345 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-5x10mg | MyBiosource | 5x10mg | EUR 1410 |
Doxorubicin (Adriamycin) |
|||
MBS576816-100mg | MyBiosource | 100mg | EUR 150 |
Doxorubicin (Adriamycin) |
|||
MBS576816-200mg | MyBiosource | 200mg | EUR 180 |
Doxorubicin (Adriamycin) |
|||
MBS576816-25mg | MyBiosource | 25mg | EUR 135 |
Doxorubicin (Adriamycin) |
|||
MBS576816-500mg | MyBiosource | 500mg | EUR 245 |
Doxorubicin (Adriamycin) |
|||
MBS576816-50mg | MyBiosource | 50mg | EUR 145 |
Zoptarelin doxorubicin |
|||
HY-16532 | MedChemExpress | Get quote | Ask for price |
Description: Zoptarelin doxorubicin (AEZS-108; AN-152) is a hybrid anticancer agent, containing Zoptarelin and Doxorubicin. Zoptarelin doxorubicin has been used to research targeting tumors expressing LHRH receptors. Zoptarelin doxorubicin abolishes tumor progression and induces remarkable apoptosis in vitro[1]. |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin (Adriamycin) HCl |
|||
A1832-10 | ApexBio | 10 mg | EUR 36 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-100 | ApexBio | 100 mg | EUR 128 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-25 | ApexBio | 25 mg | EUR 52 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Antitumour antibiotic,inhibits TOPO II. |
4'O-Benzyl Doxorubicin |
|||
B788120 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 677017-23-1 |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
HY-141158 | MedChemExpress | Get quote | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
7-Deoxy Doxorubicin Aglycone |
|||
MBS6103909-1mg | MyBiosource | 1(mg | EUR 610 |
7-Deoxy Doxorubicin Aglycone |
|||
MBS6103909-5x1mg | MyBiosource | 5x1mg | EUR 2600 |
7-Deoxy Doxorubicin Aglycone (> 75%) |
|||
D232910 | Toronto Research Chemicals | 10mg | EUR 299 |
Description: 38554-25-5 |
PEGylated Liposomal Doxorubicin- 2 mg |
|||
PHPC002DX | ProFoldin | 2 mg | EUR 140.62 |
Description: This product includes 1 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
PEGylated Liposomal Doxorubicin- 20 mg |
|||
PHPC020DX | ProFoldin | 20 mg | EUR 358.62 |
Description: This product includes 10 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
Doxorubicin-hydrazone-caproyl-maleimide |
|||
D558040 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 151038-96-9 |
N-(9-Fluorenylmethoxycarbonyl) Doxorubicin |
|||
MBS651297-10mg | MyBiosource | 10mg | EUR 505 |
N-(9-Fluorenylmethoxycarbonyl) Doxorubicin |
|||
MBS651297-5x10mg | MyBiosource | 5x10mg | EUR 2125 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
IHUHELADTLW500UG | Innovative research | each | EUR 327 |
Description: Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
MBS8412854-05mg | MyBiosource | 0.5mg | EUR 505 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
MBS8412854-5x05mg | MyBiosource | 5x0.5mg | EUR 2050 |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
IHUHELADTLN200UG | Innovative research | each | EUR 427 |
Description: Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
MBS8412853-02mg | MyBiosource | 0.2mg | EUR 605 |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
MBS8412853-5x02mg | MyBiosource | 5x0.2mg | EUR 2550 |
N-Trifluoroacetyl-4'-nitobenzoate-8-(2-acetyloxy) Doxorubicin |
|||
MBS651570-025mg | MyBiosource | 0.25mg | EUR 575 |
N-Trifluoroacetyl-4'-nitobenzoate-8-(2-acetyloxy) Doxorubicin |
|||
MBS651570-5x025mg | MyBiosource | 5x0.25mg | EUR 2440 |
7,8-Desacetyl-9,10-dehydro Daunorubicinone (~90%)(Doxorubicin Impurity) |
|||
D288680 | Toronto Research Chemicals | 10mg | EUR 4281 |
Description: 1159977-24-8 |
N-(9-Fluorenylmethoxycarbonyl)-4',6,8,11-tetra-O-benzoyl Doxorubicin |
|||
MBS651513-10mg | MyBiosource | 10mg | EUR 610 |
N-(9-Fluorenylmethoxycarbonyl)-4',6,8,11-tetra-O-benzoyl Doxorubicin |
|||
MBS651513-5x10mg | MyBiosource | 5x10mg | EUR 2600 |
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy) Doxorubicin |
|||
MBS651340-5mg | MyBiosource | 5mg | EUR 575 |
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy) Doxorubicin |
|||
MBS651340-5x5mg | MyBiosource | 5x5mg | EUR 2440 |
Doxorubicin (Adriamycin, 14-Hydroxydaunomycin, Adriacin, Adriblastin, Caelyx, Dox, Doxil, Farmiblastina, FI 106, K 1039, KW 125, NSC 123127) |
|||
MBS651464-25mg | MyBiosource | 25mg | EUR 595 |
Doxorubicin (Adriamycin, 14-Hydroxydaunomycin, Adriacin, Adriblastin, Caelyx, Dox, Doxil, Farmiblastina, FI 106, K 1039, KW 125, NSC 123127) |
|||
MBS651464-5x25mg | MyBiosource | 5x25mg | EUR 2525 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
HCL-2010 | Alpha Diagnostics | 100ug | EUR 255.6 |
6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione (Doxorubicin Impurity) |
|||
T795210 | Toronto Research Chemicals | 10mg | EUR 244 |
Description: 64845-67-6 |
Recombinant Doxorubicin resistance ABC transporter permease protein drrB (drrB) |
|||
MBS1233639-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
HCL-2004 | Alpha Diagnostics | 100ug | EUR 270 |
Recombinant Doxorubicin resistance ABC transporter permease protein drrB (drrB) |
|||
MBS7013917-002mg | MyBiosource | 0.02mg | EUR 1595 |
Recombinant Doxorubicin resistance ABC transporter permease protein drrB (drrB) |
|||
MBS7013917-01mg | MyBiosource | 0.1mg | EUR 2555 |
Recombinant Doxorubicin resistance ABC transporter permease protein drrB (drrB) |
|||
MBS7013917-5x01mg | MyBiosource | 5x0.1mg | EUR 11445 |
Des-[(4-Amino-2,3,6-trideoxy-hexapyranosyl)oxy)-1-methyl] 2-Carboxylate Doxorubicin |
|||
D558001 | Toronto Research Chemicals | 100mg | EUR 4500 |
Recombinant Probable doxorubicin resistance ABC transporter permease protein drrC (drrC) |
|||
MBS1148808-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Probable doxorubicin resistance ABC transporter permease protein drrC (drrC) |
|||
MBS7013918-002mg | MyBiosource | 0.02mg | EUR 1575 |
Recombinant Probable doxorubicin resistance ABC transporter permease protein drrC (drrC) |
|||
MBS7013918-01mg | MyBiosource | 0.1mg | EUR 2540 |
Recombinant Probable doxorubicin resistance ABC transporter permease protein drrC (drrC) |
|||
MBS7013918-5x01mg | MyBiosource | 5x0.1mg | EUR 11375 |
APY29 Hydrochloride Salt |
|||
A735422 | Toronto Research Chemicals | 100mg | EUR 224 |
Doxorubicin.HCl |
|||
1527-5 | Biovision | each | EUR 183.6 |
Recombinant Mycobacterium tuberculosis Doxorubicin resistance ATP-binding protein DrrA (drrA) |
|||
MBS1188861-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Mycobacterium tuberculosis Doxorubicin resistance ATP-binding protein DrrA (drrA) |
|||
MBS1188861-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Mycobacterium tuberculosis Doxorubicin resistance ATP-binding protein DrrA (drrA) |
|||
MBS1188861-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Mycobacterium tuberculosis Doxorubicin resistance ATP-binding protein DrrA (drrA) |
|||
MBS1188861-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Mycobacterium tuberculosis Doxorubicin resistance ATP-binding protein DrrA (drrA) |
|||
MBS1188861-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
3-N-Carboxylic Acid 1-beta-D-Glucuronide-[4-(methyl)phenyl]carbamate Ester Doxorubicin |
|||
C177855 | Toronto Research Chemicals | 50mg | EUR 11200 |
Description: 211364-63-5 |
Doxorubicinol (>90%) |
|||
D558025 | Toronto Research Chemicals | 2.5mg | EUR 1929 |
Doxorubicinol |
|||
T25349-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol |